Cargando…

Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome

BACKGROUND: Recent studies demonstrate that a Mediterranean diet has beneficial metabolic effects in metabolic syndrome subjects. Since we have shown that fecal microbiota transplantation (FMT) from lean donors exerts beneficial effects on insulin sensitivity, in the present trial, we investigated t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koopen, Annefleur M., Almeida, Eduardo L., Attaye, Ilias, Witjes, Julia J., Rampanelli, Elena, Majait, Soumia, Kemper, Marleen, Levels, Johannes H. M., Schimmel, Alinda W. M., Herrema, Hilde, Scheithauer, Torsten P. M., Frei, Werner, Dragsted, Lars, Hartmann, Bolette, Holst, Jens J., O’Toole, Paul W., Groen, Albert K., Nieuwdorp, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222733/ https://www.ncbi.nlm.nih.gov/pubmed/34177842 http://dx.doi.org/10.3389/fmicb.2021.662159

Ejemplares similares

From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
por: Wortelboer, Koen, et al.
Publicado: (2022)

Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study
por: Koopen, Annefleur, et al.
Publicado: (2022)

Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety
por: Wortelboer, Koen, et al.
Publicado: (2023)

The Black Box Orchestra of Gut Bacteria and Bile Acids: Who Is the Conductor?
por: Majait, Soumia, et al.
Publicado: (2023)

Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition
por: Koopen, Annefleur M., et al.
Publicado: (2020)

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
por: Scheithauer, Torsten P. M., et al.
Publicado: (2020)

Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects
por: Bakker, Guido J., et al.
Publicado: (2019)

Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
por: Meijnikman, Abraham Stijn, et al.
Publicado: (2021)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases
por: Callender, Cengiz, et al.
Publicado: (2022)

Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD
por: Meijnikman, Abraham S., et al.
Publicado: (2021)

Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes
por: Habibe, Jayron J., et al.
Publicado: (2022)

Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome
por: Gilijamse, Pim W., et al.
Publicado: (2020)

Compensatory intestinal immunoglobulin response after vancomycin treatment in humans
por: Scheithauer, Torsten P. M., et al.
Publicado: (2021)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

The Role of the Gut Microbiota on the Beneficial Effects of Ketogenic Diets
por: Attaye, Ilias, et al.
Publicado: (2021)

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
por: Koning, Mijra, et al.
Publicado: (2023)

Characterization of Postprandial Bile Acid Profiles and Glucose Metabolism in Cerebrotendinous Xanthomatosis
por: Majait, Soumia, et al.
Publicado: (2023)

Protein Intake, Metabolic Status and the Gut Microbiota in Different Ethnicities: Results from Two Independent Cohorts
por: Bel Lassen, Pierre, et al.
Publicado: (2021)

Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome
por: de Jonge, Patrick A., et al.
Publicado: (2022)

Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders
por: Liu, Moyan, et al.
Publicado: (2022)

Pancreatic (18)F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls
por: Bakker, Guido J., et al.
Publicado: (2019)

Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity
por: Bakker, Guido J., et al.
Publicado: (2021)

Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery
por: Scheithauer, Torsten P.M., et al.
Publicado: (2022)

Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome
por: Manrique, Pilar, et al.
Publicado: (2021)

Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk
por: Warmbrunn, Moritz V., et al.
Publicado: (2021)

Protein supplementation changes gut microbial diversity and derived metabolites in subjects with type 2 diabetes
por: Attaye, Ilias, et al.
Publicado: (2023)

Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance
por: Surendran, R. Preethi, et al.
Publicado: (2018)

More, less or both?
por: Attaye, Ilias, et al.
Publicado: (2018)

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
por: Witjes, Julia J., et al.
Publicado: (2020)

Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production
por: Yildirim, Vehpi, et al.
Publicado: (2023)

Shedding light on dark matter – faecal microbiota transplantation in Europe
por: Wortelboer, Koen, et al.
Publicado: (2021)

Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice
por: Udayappan, Shanthadevi, et al.
Publicado: (2016)

Intestinal microbial metabolites in human metabolism and type 2 diabetes
por: Herrema, Hilde, et al.
Publicado: (2020)

Protocol for a double-blinded randomised controlled trial to assess the effect of faecal microbiota transplantations on thyroid reserve in patients with subclinical autoimmune hypothyroidism in the Netherlands: the IMITHOT trial
por: Fenneman, Aline C, et al.
Publicado: (2023)

Differences in faecal microbiome composition between adult patients with UCD and PKU and healthy control subjects
por: Timmer, C., et al.
Publicado: (2021)

Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
por: de Groot, Pieter, et al.
Publicado: (2021)

An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases
por: Groen, Albert K, et al.
Publicado: (2016)

Second year Russian
por: O'Toole, L M
Publicado: (1968)

The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol
por: Bouter, Kristien E. C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2q2k4spk80acuvlgo1sgtpfouc